Masahiro Tohkin Selected Research

Masahiro Tohkin Research Topics

Disease

6	Neoplasms (Cancer) 11/2023 - 01/2009
5	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2018 - 11/2008
4	Multiple Myeloma 12/2021 - 10/2019
2	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 11/2021
2	Chronic Renal Insufficiency 01/2024 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 05/2006
2	Weight Gain 01/2019 - 05/2006
1	Hyponatremia 11/2023
1	Chemical and Drug Induced Liver Injury 05/2023
1	Hemorrhage 01/2023
1	Atrial Fibrillation 01/2023
1	Stroke (Strokes) 01/2023
1	Embolism (Embolus) 01/2023
1	Pneumonia (Pneumonitis) 12/2021
1	Melanoma (Melanoma, Malignant) 11/2021
1	Fibrosarcoma 11/2021
1	Dysuria 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021
1	Cicatrix (Scar) 01/2021
1	Tumor Lysis Syndrome 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2019
1	Hepatitis B 01/2018
1	Infections 01/2018
1	Skin Diseases (Skin Disease) 01/2018
1	Heart Failure 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017
1	Lactic Acidosis 06/2015
1	Hypertrophy 01/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2012
1	Stomach Neoplasms (Stomach Cancer) 01/2012
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Hand-Foot Syndrome 01/2012
1	Hypoxia (Hypoxemia) 01/2011

Drug/Important Bio-Agent (IBA)

5	Bortezomib (Velcade)FDA Link 11/2023 - 01/2018
5	HLA-B Antigens (HLA-B)IBA 05/2023 - 11/2008
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2010
3	SodiumIBA 11/2023 - 01/2018
3	Allopurinol (Remid)FDA LinkGeneric 01/2021 - 11/2008
2	Antineoplastic Agents (Antineoplastics)IBA 11/2023 - 01/2018
2	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021 - 12/2010
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2021 - 11/2013
2	Lenalidomide (CC 5013)FDA Link 04/2020 - 01/2020
2	SymportersIBA 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
2	XenobioticsIBA 01/2015 - 01/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Immune Checkpoint InhibitorsIBA 11/2023
1	pembrolizumabIBA 11/2023
1	Cisplatin (Platino)FDA LinkGeneric 11/2023
1	Warfarin (Coumadin)FDA LinkGeneric 01/2023
1	AnticoagulantsIBA 01/2023
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	MitogensIBA 11/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2021
1	asenapine FDA Link 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	Tadalafil (Cialis)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2020
1	Thalidomide (Thalomid)FDA Link 01/2020
1	Proteasome InhibitorsIBA 10/2019
1	Diethylhexyl Phthalate (DEHP)IBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 02/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Azacitidine (5 Azacytidine)FDA Link 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	taxaneIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Drug CombinationsIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	fludarabineIBA 01/2018
1	Everolimus FDA Link 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2017
1	DiureticsIBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2015
1	Metformin (Glucophage)FDA LinkGeneric 06/2015
1	Phenobarbital (Luminal)FDA Link 11/2013
1	Zonisamide (Zonegran)FDA LinkGeneric 11/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2013
1	Tumor Biomarkers (Tumor Markers)IBA 01/2012
1	Fluorouracil (Carac)FDA LinkGeneric 01/2012
1	Carcinoembryonic AntigenIBA 01/2012
1	CarbohydratesIBA 01/2012
1	AntigensIBA 01/2012
1	Capecitabine (Xeloda)FDA Link 01/2012
1	ProdrugsIBA 01/2012
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2011
1	ElementsIBA 01/2011

Therapy/Procedure

7	Therapeutics 11/2021 - 03/2005
4	Drug Therapy (Chemotherapy) 11/2021 - 01/2010
1	Kampo Medicine (Kampo) 05/2023
1	Antineoplastic Combined Chemotherapy Protocols 01/2018
1	Time-to-Treatment 01/2012